Reversal of subclinical left ventricular dysfunction by antihypertensive treatment: A prospective trial of nebivolol against metoprolol

Journal of Hypertension

Volumn 29, Issue 4, 2011, Pages 809-817

  Vinereanu, Dragos ^a,c   Gherghinescu, Carmen ^a   Ciobanu, Andrea O ^a   Magda, Stefania ^a   Niculescu, Natalia ^a   Dulgheru, Raluca ^a   Dragoi, Ruxandra ^a   Lautaru, Alexandra ^a   Cinteza, Mircea ^a   Fraser, Alan G ^b  

^a CAROL DAVILA UNIVERSITY OF MEDICINE AND PHARMACY   (Romania)

^b CARDIFF UNIVERSITY   (United Kingdom)

^c University of Medicine and Pharmacy Carol Davila ^*  (Romania)

Author keywords

metoprolol; myocardial function; nebivolol; stress echocardiography; tisssue Doppler

Indexed keywords

CORVITOL; HYDROCHLOROTHIAZIDE; METOPROLOL; NEBIVOLOL; UNCLASSIFIED DRUG;

ADULT; ANXIETY; ARTICLE; CARDIOVASCULAR PARAMETERS; CONTROLLED STUDY; DIABETES MELLITUS; DIASTOLIC BLOOD PRESSURE; DISEASE SEVERITY; DRUG TOLERABILITY; ERECTILE DYSFUNCTION; FATIGUE; FEMALE; FLOW PROPAGATION VELOCITY; HEART ATRIUM FIBRILLATION; HEART LEFT VENTRICLE FAILURE; HEART LEFT VENTRICLE FUNCTION; HEART LEFT VENTRICLE HYPERTROPHY; HEART RATE; HEART VENTRICLE EJECTION TIME; HUMAN; HYPERCHOLESTEROLEMIA; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; MEAN LONGITUDINAL DISPLACEMENT; MEAN LONGITUDINAL EARLY DIASTOLIC VELOCITY; OPEN STUDY; PARALLEL DESIGN; PAROXYSMAL HEART ATRIUM FIBRILLATION; PRIORITY JOURNAL; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL; SIDE EFFECT; SYSTOLIC BLOOD PRESSURE;

EID: 79952768676     PISSN: 02636352     EISSN: None     Source Type: Journal    
DOI: 10.1097/HJH.0b013e3283442f37     Document Type: Article

References (53)

1. Tzemos N, Lim PO, MacDonald TM. Nebivolol reverses endothelial dysfunction in essential hypertension. A randomised, double-blind, crossover study. Circulation 2001; 104:511-514. (Pubitemid 32738117)
2. Georgescu A, Popov D, Dragan E, Dragomir E, Badila E. Protective effects of nebivolol and reversal of endothelial dysfunction in diabetes associated with hypertension. Eur J Pharmacol 2007; 570:149-158. (Pubitemid 47247683)
3. McNeely W, Goa KL. Nebivolol in the management of essential hypertension. A review. Drugs 1999; 57:633-651. (Pubitemid 29196925)
4. Greenbaum RA, Ho SY, Gibson DG, Becker AE, Anderson RH. Left ventricular fibre architecture in man. Br Heart J 1981; 45:248-263. (Pubitemid 11137851)
5. Vinereanu D, Nicolaides E, Boden L, Payne N, Jones CJ, Fraser AG. Conduit arterial stiffness is associated with impaired left ventricular subendocardial function. Heart 2003; 89:449-450. (Pubitemid 36379425)
6. Vinereanu D, Florescu N, Sculthorpe N, Tweddel AC, Stephens MR, Fraser AG. Differentiation between pathologic and physiologic left ventricular hypertrophy by tissue Doppler assessment of long-axis function in patients with hypertrophic cardiomyopathy or systemic hypertension and in athletes. Am J Cardiol 2001; 88:53-58. (Pubitemid 32553892)
7. Vinereanu D, Nicolaides E, Tweddel AC, Madler CF, Holst B, Boden LE, et al. Subclinical left ventricular dysfunction in asymptomatic patients with type 2 diabetes mellitus, related to serum lipids and glycated haemoglobin. Clin Sci (Lond) 2003; 105:591-599. (Pubitemid 37421654)
8. Lekakis JP, Protogerou A, Papamichael C, Vamvakou G, Iconomidis I, Fici F, Mavrikakis M. Effect of nebivolol and atenolol on brachial artery flowmediated vasodilation in patients with coronary artery disease. Cardiovasc Drugs Ther 2005; 19:277-281. (Pubitemid 41778808)
9. Mahmud A, Feely J. Beta-blockers reduce aortic stiffness in hypertension but nebivolol, not atenolol, reduces wave reflection. Am J Hypertens 2008; 21:663-667. (Pubitemid 351733365)
10. Dhakam Z, Yasmin, McEniery CM, Burton T, Brown MJ, Wilkinson IB. A comparison of atenolol and nebivolol in isolated systolic hypertension. J Hypertens 2008; 26:351-356.
11. Celik T, Iyisoy A, Kursaklioglu H, Kardesoglu E, Kilic S, Turhan H, et al. Comparative effects of nebivolol and metoprolol on oxidative stress, insulin resistance, plasma adiponectin and soluble P-selectin levels in hypertensive patients. J Hypertens 2006; 24:591-596. (Pubitemid 43261924)
12. European Study Group on Diastolic Heart Failure. How to diagnose diastolic heart failure. Eur Heart J 1998; 19:990-1003.
13. Lang RM, Bierig M, Devereux RB, Flachskampf FA, Foster E, Pellikka PA, et al., American Society of Echocardiography's Nomenclature and Standards Committee; Task Force on Chamber Quantification; American College of Cardiology Echocardiography Committee; American Heart Association; European Association of Echocardiography, European Society of Cardiology. Recommendations for chamber quantification. Eur J Echocardiogr 2006; 7:79-108. (Pubitemid 43257193)
14. Brun P, Tribouilloy C, Duval AM, Iserin L, Meguira A, Pelle G, Dubois-Rande JL. Left ventricular flow propagation during early filling is related to wall relaxation: a color M-mode Doppler analysis. J Am Coll Cardiol 1992; 20:420-432.
15. Nagueh SF, Middleton KJ, Kopelen HA, Zoghbi WA, Quinones MA. Doppler tissue imaging: a noninvasive technique for evaluation of left ventricular relaxation and estimation of filling pressures. J Am Coll Cardiol 1997; 30:1527-1533. (Pubitemid 27486472)
16. Fraser AG, Payne N, Mädler CF, Janerot-Sjøberg B, Lind B, Grocott-Mason RM, et al. Feasibility and reproducibility of off-line tissue Doppler measurement of regional myocardial function during dobutamine stress echocardiography. Eur J Echocardiogr 2003; 4:43-53. (Pubitemid 36204389)
17. Vinereanu D, Nicolaides E, Tweddel AC, Fraser AG. 'Pure' diastolic dysfunction is associated with long-axis systolic dysfunction. Implications for the diagnosis and classification of heart failure. Eur J Heart Fail 2005; 7:820-828. (Pubitemid 41125900)
18. Bland M. An introduction to medical statistics. Oxford, UK: Oxford University Press; 1996; pp. 334-335.
19. Poulsen SH, Andersen NH, Ivarsen PI, Mogensen CE, Egeblad H. Doppler tissue imaging reveals systolic dysfunction in patients with hypertension and apparent 'isolated' diastolic dysfunction. J Am Soc Echocardiogr 2003; 16:724-731. (Pubitemid 37391026)
20. Di Bello V, Giorgi D, Pedrinelli R, Talini E, Palagi C, Delle Donne MG, et al. Left ventricular hypertrophy and its regression in essential arterial hypertension. A tissue Doppler imaging study. Am J Hypertens 2004; 17:882-890. (Pubitemid 39361660)
21. Hare JL, Brown JK, Marwick TH. Association of myocardial strain with left ventricular geometry and progression of hypertensive heart disease. Am J Cardiol 2008; 102:87-91.
22. Conrad CH, Brooks WW, Hayes JA, Sen S, Robinson KG, Bing OH. Myocardial fibrosis and stiffness with hypertrophy and heart failure in the spontaneously hypertensive rat. Circulation 1995; 91:161-170.
23. Mädler CF, Payne N, Wilkenshoff U, Cohen A, Derumeaux GA, Pié rard LA, et al., Myocardial Doppler in Stress Echocardiography (MYDISE) Study Investigators. Noninvasive diagnosis of coronary artery disease by quantitative stress echocardiography: optimal diagnostic models using offline tissue Doppler in the MYDISE study. Eur Heart J 2003; 24: 1584-1594. (Pubitemid 37020932)
24. Niculescu N, Gherghinescu C, Cinteza M, Madler CF, Fraser AG, Vinereanu D. Patients with arterial hypertension and no coronary heart disease had subclinical left ventricular dysfunction as assessed by tissue Doppler echocardiography [abstract]. Eur J of Echocardiogr 2006; 7:S110.
25. Mottram PM, Haluska B, Leano R, Cowley D, Stowasser M, Marwick TH. Effect of aldosterone antagonism on myocardial dysfunction in hypertensive patients with diastolic heart failure. Circulation 2004; 110:558-565. (Pubitemid 39031173)
26. Solomon SD, Janardhanan R, Verma A, Bourgoun M, Daley WL, Purkayastha D, et al., Valsartan In Diastolic Dysfunction (VALIDD) Investigators. Effect of angiotensin receptor blockade and antihypertensive drugs on diastolic function in patients with hypertension and diastolic dysfunction: a randomised trial. Lancet 2007; 369:2079-2087. (Pubitemid 46935945)
27. Mottram PM, Haluska BA, Leano R, Carlier S, Case C, Marwick TH. Relation of arterial stiffness to diastolic dysfunction in hypertensive heart disease. Heart 2005; 91:1551-1556. (Pubitemid 41697593)
28. Williams B, Lacy PS, Thom SM, Cruickshank K, Stanton A, Collier D, et al., CAFE Investigators; Anglo-Scandinavian Cardiac Outcomes Trial Investigators; CAFE Steering Committee and Writing Committee. Differential impact of blood pressure-lowering drugs on central aortic pressure and clinical outcomes: principal results of the Conduit Artery Function Evaluation (CAFE) study. Circulation 2006; 113:1213-1225.
29. Lenkiewicz JE, Davies MJ, Rosen D. Collagen in human myocardium as a function of age. Cardiovasc Res 1972; 6:549-555.
30. Heng MK, Janz RF, Jobin J. Estimation of regional stress in the left ventricular septum and free wall: an echocardiographic study suggesting a mechanism for asymmetric septal hypertrophy. Am Heart J 1985; 110:84-90. (Pubitemid 16119685)
31. Verdecchia P, Brignole M, Delfino G, Queirolo C, De Marchi G, Bertulla A. Systolic time intervals as possible predictors of pressure response to sustained beta-adrenergic blockade in arterial hypertension. A withinpatient, placebo-controlled study. Hypertension 1983; 5:140-146. (Pubitemid 13179802)
32. Rozec B, Erfanian M, Laurent K, Trochu JN, Gauthier C. Nebivolol, a vasodilating selective beta(1)-blocker, is a beta(3)-adrenoceptor agonist in the nonfailing transplanted human heart. J Am Coll Cardiol 2009; 53:1532-1538.
33. Galderisi M, D'Errico A, Sidiropulos M, Innelli P, de Divitiis O, de Simone G. Nebivolol induces parallel improvement of left ventricular filling pressure and coronary flow reserve in uncomplicated arterial hypertension. J Hypertens 2009; 27:2108-2115.
34. Nodari S, Metra M, Dei Cas L. Beta-blocker treatment of patients with diastolic heart failure and arterial hypertension. A prospective, randomized, comparison of the long-term effects of atenolol vs. nebivolol. Eur J Heart Fail 2003; 5:621-627. (Pubitemid 38043967)
35. Task Force for Diagnosis and Treatment of Acute and Chronic Heart Failure of European Society of Cardiology. ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2008: the Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2008 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association of the ESC (HFA) and endorsed by the European Society of Intensive Care Medicine (ESICM). Eur Heart J 2008; 29:2388-2442.
36. Page CM, Khir AW, Hughes AD, Chung R, Henein MY. Normal asynchrony of left ventricular long and short axes: their relationship with aortic hemodynamics. Int J Cardiol 2010; 142:166-171.
37. Ciobanu A, Magda S, Florescu M, Dulgheru R, Dabelea S, Lichiardopol R, et al. Endothelial dysfunction induces subclinical reduction of longitudinal left ventricular deformation into the diabetic heart [abstract]. Eur J Echocardiogr 2009; 10:136.
38. Hjalmarson A, Goldstein S, Fagerberg B, Wedel H, Waagstein F, Kjekshus J, et al. Effects of controlled-release metoprolol on total mortality, hospitalizations, and well being in patients with heart failure: the Metoprolol CR/XL Randomized Intervention Trial in congestive heart failure (MERITHF). MERIT-HF Study Group. JAMA 2000; 283:1295-1302. (Pubitemid 30129796)
39. Flather MD, Shibata MC, Coats AJ, Van Veldhuisen DJ, Parkhomenko A, Borbola J, et al., SENIORS Investigators. Randomized trial to determine the effect of nebivolol on mortality and cardiovascular hospital admission in elderly patients with heart failure (SENIORS). Eur Heart J 2005; 26:215-225. (Pubitemid 40222359)
40. Ghio S, Magrini G, Serio A, Klersy C, Fucili A, Ronaszè ki A, et al., SENIORS investigators. Effects of nebivolol in elderly heart failure patients with or without systolic left ventricular dysfunction: results of the SENIORS echocardiographic substudy. Eur Heart J 2006; 27:562-568.
41. Aurigemma GP, Zile MR, Gaasch WH. Lack of relationship between Doppler indices of diastolic function and left ventricular pressure transients in patients with definite diastolic heart failure. Am Heart J 2004; 148:530-536.
42. Tuncer M, Guntekin U, Gunes Y, Gumrukcuoglu HA, Eryonucu B. Differential effects of nebivolol and atenolol on transmitral diastolic filling parameters in patients with essential hypertension. Adv Ther 2008; 25:619-626.
43. Triposkiadis F, Giamouzis G, Kelepeshis G, Sitafidis G, Skoularigis J, Demopoulos V. Acute hemodynamic effects of moderate doses of nebivolol versus metoprolol in patients with systolic heart failure. Int J Clin Pharmacol Ther 2007; 45:71-77. (Pubitemid 46344138)
44. Hansson L, Hedner T, Dahlöf B. Prospective Randomized Open Blinded End-Point (PROBE) study. A novel design for intervention trials. Prospective Randomized Open Blinded End-Point. Blood Press 1992; 1:113-119.
45. Smith DH, Neutel JM, Lacourciè re Y, Kempthorne-Rawson J. Prospective, Randomized, Open-Label, Blinded-Endpoint (PROBE) designed trials yield the same results as double-blind, placebo-controlled trials with respect to ABPM measurements. J Hypertens 2003; 21:1291-1298.
46. Andersen NH, Poulsen SH, Poulsen PL, Knudsen ST, Helleberg K, Hansen KW, et al. Left ventricular dysfunction in hypertensive patients with type 2 diabetes mellitus. Diabet Med 2005; 22:1218-1225. (Pubitemid 41224183)
47. Pavlopoulos H, Grapsa J, Stefanadi E, Philippou E, Dawson D, Nihoyannopoulos P. Is it only diastolic dysfunction? Segmental relaxation patterns and longitudinal systolic deformation in systemic hypertension. Eur J Echocardiogr 2008; 9:741-747.
48. Rovner A, de las Fuentes L, Waggoner AD, Memon N, Chohan R, Dá vila- Román VG. Characterization of left ventricular diastolic function in hypertension by use of Doppler tissue imaging and color M-mode techniques. J Am Soc Echocardiogr 2006; 19:872-879. (Pubitemid 43974909)
49. Buakhamsri A, Popovic ZB, Lin J, Lim P, Greenberg NL, Borowski AG, et al. Impact of left ventricular volume/mass ratio on diastolic function. Eur Heart J 2009; 30:1213-1221.
50. Asada-Kamiguchi J, Tabata T, Popovic ZB, Greenberg NL, Kim YJ, Garcia MJ, et al. Noninvasive assessment of left ventricular relaxation during atrial fibrillation using mitral flow propagation velocity. Eur J Echocardiogr 2009; 10:826-832.
51. Bess RL, Khan S, Rosman HS, Cohen GI, Allebban Z, Gardin JM. Technical aspects of diastology: why mitral inflow and tissue Doppler imaging are the preferred parameters? Echocardiography 2006; 23:332-339.
52. Yeter E, Akçay M, Keleş T, Durmaz T, Bayram NA, Ozdemir L, et al. The association of diastolic dysfunction and circadian variation of blood pressure in prehypertension. J Am Soc Echocardiogr 2009; 22:726-731.
53. Ciobanu A, Magda S, Cinteza M, Vinereanu D. A comparison of indapamide SR 1.5mg with hydrochlorothiazide 25 mg, in combination with an ACEinhibitor, in patients with hypertension and diabetes. The AISHA study. Maedica - J Clin Med 2007; 2:307-310.